The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20201510: GI Partners Fund V LP; Charlesbank Equity Fund VII, Limited Partnership
2009003 Informal Interpretation
FTC Staff Comment to Texas Health and Human Services Commission Regarding Certificate of Public Advantage Applications
FTC Staff Comment to Attorney General of Texas Concerning Certified Registered Nurse Anesthetists (CRNA) Regulations
20201253: Sunrun Inc.; Blackstone Capital Partners VI L.P.
20201255: Blackstone Capital Partners VI L.P.; Sunrun Inc.
20201460: Greenbridge Investment L.P.; Neo4j, Inc.
20201478: Emerson Electric Co.; Open Systems International, Inc.
Elanco Animal Health and Bayer
In July 2020, the FTC required global suppliers of animal products, Elanco Animal Health, Inc. and Bayer Animal Health GmbH, to divest three animal health products to settle charges that Elanco’s proposed $7.6 billion acquisition of Bayer would likely be anticompetitive in those markets. On Sept. 11, 2020, the Commission announced the final consent agreement in this matter.
OMICS Group Inc.
In April 2019, the FTC announced that a federal district court judge ordered Srinubabu Gedela and his companies to pay more than $50.1 million to resolve FTC charges that they made deceptive claims about the nature of their conferences and publications, and hid steep publication fees. The court ruling resolved a 2016 Commission complaint alleging that Gedela and the companies falsely advertised online scientific and medical academic journals and international conferences, and deceptively claimed the journals provided authors with rigorous peer review and editorial boards comprised of prominent academics.